A
Our Vision: To understand and use the therapeutic potential of the cannabis plant and thereby improve the quality of life for patients. Our Mission: To make cannabis-based medicines available to a wide patient population through the development of innovative, rigorously tested and regulator-approved products.
Investor insights
Funding rounds participated in
$6.8M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2019
Funding rounds raised
Total raised
$6.8M
from 1 investors over 1 rounds
A
Avextra raised $6.8M on January 12, 2025
Investors: European Union